INTENSITY THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that INTENSITY THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($2.67M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($2.54M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($2.54M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($3.35M) | May 13, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($3.35M) | Nov 6, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($3.35M) | Aug 7, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($3.51M) | Nov 6, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($4.97M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($4.97M) | Aug 7, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($4.60M) | Aug 7, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($4.60M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($4.60M) | May 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.33M) | Nov 13, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($3.70M) | Nov 13, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($3.70M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.34M) | May 9, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($1.34M) | Aug 8, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($1.34M) | Nov 13, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($1.77M) | Nov 13, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($1.93M) | Aug 14, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($2.73M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($2.71M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($3.39M) | May 13, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($3.57M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($5.07M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($4.74M) | May 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.49M) | Nov 13, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.22M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.25M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($1.77M) | Nov 13, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($1.93M) | Aug 14, 2023 |